"AIDS Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.
| Descriptor ID |
D016915
|
| MeSH Number(s) |
D20.215.894.899.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "AIDS Vaccines".
Below are MeSH descriptors whose meaning is more specific than "AIDS Vaccines".
This graph shows the total number of publications written about "AIDS Vaccines" by people in this website by year, and whether "AIDS Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "AIDS Vaccines" by people in Profiles.
-
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity. J Virol. 2025 12 23; 99(12):e0125625.
-
Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses. Front Immunol. 2025; 16:1601865.
-
Acceptability of a Future HIV Vaccine: A Rapid Scoping Review. J Acquir Immune Defic Syndr. 2024 07 01; 96(3):197-207.
-
Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathog. 2018 02; 14(2):e1006888.
-
Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV. Vaccine. 2016 11 21; 34(48):5886-5894.
-
Teaching a Clone to Walk, One Step at a Time. Cell. 2016 Sep 08; 166(6):1360-1361.
-
The Human Immune Response to HIV and its Impact in the Potential Development of an Inactivated HIV Vaccine. AIDS Rev. 2016 Jul-Sep; 18(3):151-157.
-
A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV. PLoS One. 2015; 10(8):e0136862.
-
HIV inactivation: time for a second look. AIDS. 2015 Jan 02; 29(1):129-31.
-
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. J Infect Dis. 2014 Jul 01; 210(1):99-110.